order tirzepatide FDA confirms shortage is still over, gives compounders a grace period Order Tirzepatide (50 mg) |

Diabetes, Obesity & Metabolism (PMID 42219271)

47 In patients with overweight or obesity without diabetes, the Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) trial showed that tirzepatide 15 mg weekly led to a mean body weight reduction of 20.9% after 72 weeks of treatment, compared with 3.1% with placebo

Kline most patients get started within 24 hours

But while those who need it will be able to benefit more readily, two issues come with this more accessible weight-loss drug

The drug class, GLP-1 (glucagon-like peptide) receptor agonists have been on the market for diabetes treatment for more than 15 years, says Donna H